Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|April 28, 2022
Electrocardiographic abnormalities in childhood cancer survivors treated with cardiotoxic therapy: a systematic reviewEsmée C de Baat, Elizabeth A M Feijen, Jorrit B van Niekerk, et al.
Cancer Medicine|April 6, 2017
Risk and associated risk factors of hospitalization for specific health problems over time in childhood cancer survivors: a medical record linkage studyAnna Font-Gonzalez, Elizabeth Lieke A M Feijen, Ronald B Geskus, et al.
JACC. Cardiooncology|August 16, 2021
Refining the 10-Year Prediction of Left Ventricular Systolic Dysfunction in Long-Term Survivors of Childhood CancerJan M Leerink, Helena J H van der Pal, Leontien C M Kremer, et al.
Cancer Medicine|May 3, 2026
Early Detection of Acute and Early-Onset Cancer Therapy-Related Cardiac Dysfunction in Children With Cancer Using a Multiparametric Approach: Methodological Aspects of the EARLY StudyTheodorus W Kouwenberg, Heynric B Grotenhuis, Leontien C M Kremer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood CancerElizabeth A M Feijen, Wendy M Leisenring, Kayla L Stratton, et al.
Journal of Cancer Survivorship : Research and Practice|March 27, 2021
Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic reviewRemy Merkx, Jan M Leerink, Esmée C de Baat, et al.
European Journal of Heart Failure|August 19, 2020
The cancer patient and cardiologyJosé Luis Zamorano, Christer Gottfridsson, Riccardo Asteggiano, et al.
Pediatric Blood & Cancer|September 4, 2020
Large variation in assessment and outcome definitions to describe the burden of long-term morbidity in childhood cancer survivors: A systematic reviewNina Streefkerk, Lisanne C E Fioole, Josien G M Beijer, et al.
JACC. Cardiooncology|August 16, 2021
Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art ReviewJan M Leerink, Esmée C de Baat, Elizabeth A M Feijen, et al.
JAMA Oncology|February 1, 2019
Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset CardiotoxicityElizabeth A M Feijen, Wendy M Leisenring, Kayla L Stratton, et al.
Pageof 5